AI
Thursday, April 02, 2020 10:07:56 PM
Recap of company trials...
As CTIX: https://clinicaltrials.gov/ct2/results?cond=&term=cellceutix&cntry=&state=&city=&dist=
As IPIX: https://clinicaltrials.gov/ct2/results?cond=&term=%22innovation+pharmaceuticals%22&cntry=&state=&city=&dist=&Search=Search
False comparison... not only does the other company have ZERO clinical trials, this one has two that are ph3 ready.
And, a couple of labs researching covid found enough data on Brilacidin to contact the company for testing against COVID.
Brilacidin research: https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=brilacidin&oq=br
Kevetrin research: https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=kevetrin&btnG=
Lack of sufficient funds has been the killer here. Not the science.
Brilacidin has two ph3 ready trials in 2 different indications.
As CTIX: https://clinicaltrials.gov/ct2/results?cond=&term=cellceutix&cntry=&state=&city=&dist=
As IPIX: https://clinicaltrials.gov/ct2/results?cond=&term=%22innovation+pharmaceuticals%22&cntry=&state=&city=&dist=&Search=Search
False comparison... not only does the other company have ZERO clinical trials, this one has two that are ph3 ready.
And, a couple of labs researching covid found enough data on Brilacidin to contact the company for testing against COVID.
Brilacidin research: https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=brilacidin&oq=br
Kevetrin research: https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=kevetrin&btnG=
Lack of sufficient funds has been the killer here. Not the science.
Brilacidin has two ph3 ready trials in 2 different indications.
To follow KarinCA, click here then click "Follow This Member" under my photo.
Be kinder than necessary, for everyone you meet is fighting some kind of battle.
